Max Robotics — Global Service Robot Directory + US Certification

About

Janessa Laskin is a leading oncologist and researcher whose work has profoundly shaped the understanding and treatment of lung cancer and other thoracic malignancies. Her primary research areas include precision oncology, biomarker-driven therapies, and the molecular characterization of non-small cell lung cancer (NSCLC). Dr. Laskin is best known for her pioneering contributions to personalized medicine, particularly through her leadership in the "Personalized Onco-Genomics" (POG) program, which integrates whole-genome and transcriptome sequencing to guide treatment decisions for advanced cancer patients. Her landmark studies have demonstrated the clinical utility of comprehensive genomic profiling, revealing actionable mutations in a significant proportion of patients and improving outcomes. Among her notable works is the widely referenced "Handbook of Lung Cancer and Other Thoracic Malignancies," a comprehensive resource that has garnered over 4 citations and serves as a key educational tool for clinicians and researchers. Her impact is further reflected in her extensive publication record, with papers collectively cited thousands of times, underscoring her role in advancing targeted therapies and immunotherapy. Dr. Laskin’s dedication to translating genomic discoveries into clinical practice has made her a pivotal figure in thoracic oncology.